COOPER COS INC/THE (COO)

US2166485019 - Common Stock

90.64  +0.89 (+0.99%)

After market: 90.64 0 (0%)

Fundamental Rating

5

COO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 193 industry peers in the Health Care Equipment & Supplies industry. While COO belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. COO has a correct valuation and a medium growth rate.



7

1. Profitability

1.1 Basic Checks

In the past year COO was profitable.
In the past year COO had a positive cash flow from operations.
Each year in the past 5 years COO has been profitable.
In the past 5 years COO always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of COO (2.42%) is better than 75.52% of its industry peers.
The Return On Equity of COO (3.78%) is better than 75.00% of its industry peers.
With a decent Return On Invested Capital value of 3.99%, COO is doing good in the industry, outperforming 75.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for COO is below the industry average of 8.53%.
Industry RankSector Rank
ROA 2.42%
ROE 3.78%
ROIC 3.99%
ROA(3y)12.18%
ROA(5y)9.5%
ROE(3y)17.23%
ROE(5y)14.16%
ROIC(3y)4.13%
ROIC(5y)4.98%

1.3 Margins

Looking at the Profit Margin, with a value of 7.93%, COO belongs to the top of the industry, outperforming 81.77% of the companies in the same industry.
COO's Profit Margin has improved in the last couple of years.
COO's Operating Margin of 15.87% is amongst the best of the industry. COO outperforms 88.02% of its industry peers.
COO's Operating Margin has been stable in the last couple of years.
The Gross Margin of COO (66.09%) is better than 71.35% of its industry peers.
COO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.87%
PM (TTM) 7.93%
GM 66.09%
OM growth 3Y4.97%
OM growth 5Y-0.95%
PM growth 3Y-5.84%
PM growth 5Y8.19%
GM growth 3Y1.29%
GM growth 5Y0.36%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COO is destroying value.
COO has less shares outstanding than it did 1 year ago.
COO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, COO has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.82 indicates that COO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.82, COO is in the better half of the industry, outperforming 71.88% of the companies in the same industry.
The Debt to FCF ratio of COO is 20.38, which is on the high side as it means it would take COO, 20.38 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 20.38, COO is doing good in the industry, outperforming 72.40% of the companies in the same industry.
A Debt/Equity ratio of 0.36 indicates that COO is not too dependend on debt financing.
COO's Debt to Equity ratio of 0.36 is in line compared to the rest of the industry. COO outperforms 42.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 20.38
Altman-Z 3.82
ROIC/WACC0.41
WACC9.65%

2.3 Liquidity

A Current Ratio of 1.86 indicates that COO should not have too much problems paying its short term obligations.
COO has a Current ratio of 1.86. This is in the lower half of the industry: COO underperforms 76.04% of its industry peers.
COO has a Quick Ratio of 1.08. This is a normal value and indicates that COO is financially healthy and should not expect problems in meeting its short term obligations.
COO has a Quick ratio of 1.08. This is amonst the worse of the industry: COO underperforms 80.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.08

4

3. Growth

3.1 Past

The earnings per share for COO have decreased strongly by -66.43% in the last year.
COO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.60% yearly.
Looking at the last year, COO shows a quite strong growth in Revenue. The Revenue has grown by 8.48% in the last year.
Measured over the past years, COO shows a small growth in Revenue. The Revenue has been growing by 7.24% on average per year.
EPS 1Y (TTM)-66.43%
EPS 3Y-30.76%
EPS 5Y-22.6%
EPS growth Q2Q17.24%
Revenue 1Y (TTM)8.48%
Revenue growth 3Y13.91%
Revenue growth 5Y7.24%
Revenue growth Q2Q8.51%

3.2 Future

COO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 50.55% yearly.
COO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.30% yearly.
EPS Next Y11.91%
EPS Next 2Y11.61%
EPS Next 3Y12.16%
EPS Next 5Y50.55%
Revenue Next Year8.16%
Revenue Next 2Y7.46%
Revenue Next 3Y7.17%
Revenue Next 5Y6.3%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.22, COO can be considered very expensive at the moment.
Based on the Price/Earnings ratio, COO is valued a bit cheaper than the industry average as 79.17% of the companies are valued more expensively.
COO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.28.
A Price/Forward Earnings ratio of 22.74 indicates a rather expensive valuation of COO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COO indicates a rather cheap valuation: COO is cheaper than 82.81% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of COO to the average of the S&P500 Index (20.88), we can say COO is valued inline with the index average.
Industry RankSector Rank
PE 27.22
Fwd PE 22.74

4.2 Price Multiples

COO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. COO is cheaper than 79.69% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, COO is valued a bit cheaper than 70.83% of the companies in the same industry.
Industry RankSector Rank
P/FCF 132.47
EV/EBITDA 21.36

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COO does not grow enough to justify the current Price/Earnings ratio.
COO has a very decent profitability rating, which may justify a higher PE ratio.
COO's earnings are expected to grow with 12.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.29
PEG (5Y)N/A
EPS Next 2Y11.61%
EPS Next 3Y12.16%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.02%, COO is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.68, COO pays a better dividend. On top of this COO pays more dividend than 90.10% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, COO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.02%

5.2 History

The dividend of COO decreases each year by -36.53%.
COO has been paying a dividend for at least 10 years, so it has a reliable track record.
COO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-36.53%
Div Incr Years0
Div Non Decr Years15

5.3 Sustainability

COO pays out 1.03% of its income as dividend. This is a sustainable payout ratio.
DP1.03%
EPS Next 2Y11.61%
EPS Next 3Y12.16%

COOPER COS INC/THE

NASDAQ:COO (5/3/2024, 4:48:33 PM)

After market: 90.64 0 (0%)

90.64

+0.89 (+0.99%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.02B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.02%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 27.22
Fwd PE 22.74
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.29
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.42%
ROE 3.78%
ROCE
ROIC
ROICexc
ROICexgc
OM 15.87%
PM (TTM) 7.93%
GM 66.09%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.86
Quick Ratio 1.08
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-66.43%
EPS 3Y-30.76%
EPS 5Y
EPS growth Q2Q
EPS Next Y11.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.48%
Revenue growth 3Y13.91%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y